1. Postvaccination morphea profunda in a child.
- Author
-
Khaled A, Kharfi M, Zaouek A, Rameh S, Zermani R, Fazaa B, and Kamoun MR
- Subjects
- Antimetabolites, Antineoplastic therapeutic use, Child, Preschool, Female, Humans, Injections, Intramuscular, Methotrexate therapeutic use, Scleroderma, Localized drug therapy, Scleroderma, Localized pathology, Steroids therapeutic use, Diphtheria-Tetanus-Pertussis Vaccine administration & dosage, Diphtheria-Tetanus-Pertussis Vaccine adverse effects, Scleroderma, Localized etiology, Thigh
- Abstract
We report a new case of postvaccination morphea profunda (MP) in a child and discuss its different clinical presentations, prognosis, and therapy and its relationship with "solitary morphea profunda." A 2-year-old healthy girl presented with an induration of the anterior aspect of the left thigh of 9 months duration. The lesion had appeared 3 months after a third dose of diphtheria-tetanus-pertussis vaccine. Cutaneous examination showed an induration of 7 × 7 cm with an "orange peel" texture after pinching the skin. Histologic examination confirmed the diagnosis of MP. Systemic steroids (1 mg/kg/day) led to the stabilization of the lesion. After 4 months of treatment, we began the concomitant use of oral methotrexate (10 mg/wk) for 2 months. Methotrexate was then continued alone for 10 months, leading to a significant regression of the induration with no relapse., (© 2011 Wiley Periodicals, Inc.)
- Published
- 2012
- Full Text
- View/download PDF